Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Noven revenue
Noven's revenue is $520.0 million.
What is Noven's revenue?
- Noven has 586 employees, and the revenue per employee ratio is $887,372.
- Noven peak revenue was $520.0M in 2024.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Noven competitors
Noven's top competitor, AstraZeneca, earned an annual revenue of $25.9B.
Noven's smallest competitor is Prometheon Pharma with revenue of $160.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Avanir Pharmaceuticals | $65,825 | $115.0M | 200 | - |
| FUJIFILM Irvine Scientific | $62,827 | $300.0M | 361 | - |
| Prometheon Pharma | $51,894 | $160,000 | 3 | - |
| Oyster Point Pharma | $44,982 | $2.2M | 86 | - |
| Antares Pharma | $63,492 | $184.0M | 165 | - |
| Alpharma | $61,984 | $350.0M | 2,000 | - |
| Depomed | $72,486 | $342.7M | 494 | - |
| KV Pharmaceutical | $58,657 | $91.0M | 7,500 | - |
| Emisphere Technologies | $71,999 | $1.2M | 76 | - |
| Pharmacia | $76,833 | $130.0M | 350 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Noven highest paying jobs
Zippia gives an in-depth look into the details of Noven, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Noven. The employee data is based on information from people who have self-reported their past or current employments at Noven. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Noven. The data presented on this page does not represent the view of Noven and its employees or that of Zippia.
Noven may also be known as or be related to Noven, Noven Pharmaceuticals, Noven Pharmaceuticals Inc and Noven Pharmaceuticals, Inc.